期刊文献+

核基质结合区结合蛋白质1研究进展

Advances in Study on Scaffold/matrix Attachment Region Binding Protein 1
下载PDF
导出
摘要 核基质相关蛋白改变是恶性肿瘤细胞的主要表现形式,可使染色质发生折叠、基因复制保真度和基因表达发生改变。核基质结合区(MAR)结合蛋白(MARBPs)表达异常可影响染色质构成、干扰转录调控程序,致肿瘤形成。某些MARBPs特异性表达于肿瘤组织,是肿瘤诊断和预后的指标。核基质结合区结合蛋白质1(SMAR1)在乳腺癌中的表达急剧下调。本文就SMAR1在细胞生长、凋亡和肿瘤形成中的作用作一综述。 Change of nuclear matrix associated protein is one of the major phenotypes of malignant tumor cells leading to alteration in chromatin folding, the change of fidelity of genome replication and gene expression. Aberrant expression of matrix attachment region (MAR) binding proteins (MARBPs) modulates the ehromatin constitution and disruption of transcriptional network that leads to oncogenesis. Some of these proteins are expressed specifically in tumor tissue and could be served as promising diagnostic or prognostic markers. Scaffold/matrix attachment region binding protein 1 (SMAR1) expression is drastically down-regulated in breast cancer. This article reviewed the roles of SMAR1 in cell growth, apoptosis and tumorigenesis.
出处 《胃肠病学》 2012年第4期248-250,共3页 Chinese Journal of Gastroenterology
关键词 核基质结合区结合蛋白质1 肿瘤 细胞周期 转化生长因子Β NF-ΚB Scaffold/Matrix Attachment Region Binding Protein 1 Neoplasms Cell Cycle Transforming Growth Factor beta NF-kappa B
  • 相关文献

参考文献28

  • 1Nakka KK, Chattopadhyay S. Modulation of chromatin by MARs and MAR binding oncogenic transcription factor SMARI[J]. Mol Cell Biochem, 2010, 336 (1-2): 75-84.
  • 2Chattopadhyay S, Pavithra L. MARs and MARBPs: key modulators of gene regulation and disease manifestation [J]. Subcell Biochem, 2007, 41: 213-230.
  • 3Kaul-Ghanekar R, Majumdar S, Jalota A, et al. Abnormal V (D)J recombination of T cell receptor beta locus in SMAR1 transgenic mice[J]. J Biol Chem, 2005, 280 (10): 9450-9459.
  • 4Chattopadhyay S, Kaul R, Charest A, et al. SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/Matrix-associated region at the T cell receptor beta locus[J]. Genomics, 2000, 68 (1): 93-96.
  • 5Malonia SK, Sinha S, Lakshminarasimhan P, et al. Gene regulation by SMARI: Role in cellular homeostasis and cancer[J]. Biochim Biophys Acta, 2011, 1815 (1): 1-12.
  • 6Gong G, DeVries S, Chew KL, et al. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomie hybridization[J]. Clin Cancer Res, 2001, 7 (8): 2410-2414.
  • 7Miller B J, Wang D, Krahe R, et al. Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for muhiple tumor suppressors and identifies novel candidate regions[J]. Am J Hum Genet, 2003, 73 (4): 748-767.
  • 8Singh K, Mogare D, Giridharagopalan RO, et al. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion[J]. PLoS One, 2007, 2 (7): e660.
  • 9Kaul R, Mukherjee S, Ahmed F, et al. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice[J]. Int J Cancer, 2003, 103 (5): 606-615.
  • 10Jalota-Badhwar A, Kaul-Ghanekar R, Mogare D, et al. SMARl-derived P44 peptide retains its tumor suppressor function through modulation of p53[J]. J Biol Chem, 2007, 282 (13): 9902-9913.

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部